Treatment of venous thromboembolism in cancer patients: The dark side of the moon

Cecilia Becattini; Marcello Di Nisio; Laura Franco; Agnes Y.Y. Lee; Giancarlo Agnelli; Mario Mandalà

doi:10.1016/j.ctrv.2021.102190

Related publications

Article2018

Treatment of venous thromboembolism in patients with cancer: What news from clinical trials?

Melina Verso, Laura Franco, Michela Giustozzi, Cecilia Becattini, Giancarlo Agnelli

Article2020

Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer

Giancarlo Agnelli, Cecilia Becattini, Guy Meyer, Andrés J. Muñoz Martín, Menno V. Huisman, Jean M. Connors, Alexander Cohen, Rupert Bauersachs, Benjamin Brenner, Adam Torbicki, María Rosales Sueiro, Catherine Lambert, Gualberto Gussoni, Mauro Campanini, Andrea Fontanella, Giorgio Vescovo, Melina Verso

Article2014

Prophylaxis against venous thromboembolism in patients with cancer.

Melina Verso, Giancarlo Agnelli

Article2018

Apixaban versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio Study

Giancarlo Agnelli, Cecilia Becattini, Rupert Bauersachs, Benjamin Brenner, Mauro Campanini, Alexander T. Cohen, Jean M. Connors, Andrea Fontanella, Gualberto Gussoni, Menno V. Huisman, Catherine Lambert, Guy Meyer, Andrés J. Muñoz Martín, Joaquim Abreu de Sousa, Adam Torbicki, Melina Verso, Giorgio Vescovo

Article2007

OPTIMAL DURATION OF ANTICOAGULANT TREATMENT IN PATIENTS WITH VENOUS THROMBOEMBOLISM

Giancarlo Agnelli